Roche dedicates world's largest PCR-manufacturing facility in New Jersey
New site for 800 people; investment of more than 150 million US dollars
Roche dedicated its new Manufacturing Center in Branchburg, New Jersey, USA. The facility is the largest Polymerase Chain Reaction (PCR) manufacturing site in the world and was constructed to manufacture and supply Roche Diagnostics' industry-leading products based on its Nobel-prize winning PCR technology. Roche has spent more than 150 million US dollars for construction of the new structure and renovations to the existing facility. The new plant allows Roche Diagnostics to consolidate the production currently operating in various places in New Jersey to one centralized Branchburg location. The new 26,000 square meter facility will employ up to 800 people, creating approximately 350 new jobs. Foundational work on the new facility began in April 2003. "It is of utmost importance to have a facility that can respond to the increasing market demand for our PCR products," said Franz B. Humer, Chairman and CEO of the Roche Group. "Within the diagnostics industry, the existing as well as the new PCR tests of Roche Diagnostics like the FDA-cleared AmpliChip CYP450 Test belong to the most innovative products. We anticipate that the consolidation of the manufacturing processes and the integration of the New Jersey activities of Roche Diagnostics into one facility will greatly benefit our business practice as we continue to support the role of PCR technology in changing medicine."
Other news from the department manufacturing
